XFOR
X4 Pharmaceuticals, Inc
Company overview
- Market capitalization
- $298.93M
- Employees
- 45
- Latest publication
- 2026-09-29
About X4 Pharmaceuticals, Inc
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system. It offers XOLREMDI, an orally small-molecule selective antagonist of chemokine receptor CXCR4, which is in phase 3 clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. It has a license agreement with Abbisko Therapeutics Co Ltd. to manufacture and distribute XOLREMDI in mainland China, Taiwan, Hong Kong and Macau; Norgine to develop, manufacture, and commercialize mavorixafor in Europe, Australia, and New Zealand; and Genzyme Corporation for CXCR4 receptor to develop and commercialize products containing licensed compounds for all therapeutic, prophylactic and diagnostic uses. The company is headquartered in Boston, Massachusetts.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 8,806,000USD | 2,708,000USD | 2,568,000USD | 1,765,000USD | 1,973,000USD | 28,807,000USD | 1,434,000USD | 560,000USD |
| Cost Of Revenue | 1,617,000USD | 598,000USD | 387,000USD | 374,000USD | 494,000USD | 5,005,000USD | 302,000USD | 307,000USD |
| Gross Profit | 7,189,000USD | 2,110,000USD | 2,181,000USD | 1,391,000USD | 1,479,000USD | 23,802,000USD | 1,132,000USD | 253,000USD |
| Research Development | 15,079,000USD | 15,450,000USD | 18,498,000USD | 17,314,000USD | 18,184,000USD | 18,224,000USD | 21,702,000USD | 19,093,000USD |
| General And Administrative Expenses | 8,501,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 23,580,000USD | 22,416,000USD | 25,880,000USD | 28,900,000USD | 27,711,000USD | 33,244,999USD | 36,847,000USD | 34,753,000USD |
| Operating Income | -16,391,000USD | -20,306,000USD | -23,699,000USD | -27,509,000USD | -26,232,000USD | -9,443,000USD | -35,715,000USD | -34,500,000USD |
| Total Other Income Expense Net | 236,000USD | 65,000USD | -226,000USD | -2,336,000USD | 528,000USD | 9,759,000USD | -3,848,000USD | -2,181,000USD |
| Interest Income | 1,979,000USD | 2,105,000USD | 1,985,000USD | 901,000USD | 665,000USD | 1,025,000USD | 1,267,000USD | 1,871,000USD |
| Interest Expense | 2,164,000USD | 2,134,000USD | 2,186,000USD | 2,257,000USD | 2,232,000USD | 2,201,000USD | 2,304,000USD | 2,414,000USD |
| Income Before Tax | -16,155,000USD | -20,241,000USD | -23,925,000USD | -29,845,000USD | -25,704,000USD | 316,000USD | -39,563,000USD | -36,681,000USD |
| Income Tax Expense | 2,000USD | — | — | -30,000USD | 37,000USD | 34,000USD | 258,000USD | 15,000USD |
| Net Income | -16,157,000USD | -20,241,000USD | -23,925,000USD | -29,815,000USD | -25,741,000USD | 282,000USD | -39,821,000USD | -36,696,000USD |
| Selling General Administrative | — | 6,966,000USD | 43,516,000USD | 11,586,000USD | 9,527,000USD | 15,021,000USD | 15,145,000USD | 15,660,000USD |
| Net Interest Income | — | -29,000USD | -201,000USD | -1,356,000USD | -1,567,000USD | -1,176,000USD | -1,037,000USD | -543,000USD |
| Tax Provision | — | 0USD | 0USD | -30,000USD | 37,000USD | 34,000USD | 258,000USD | 15,000USD |
| Net Income From Continuing Ops | — | -20,241,000USD | -23,925,000USD | -29,815,000USD | -25,741,000USD | 282,000USD | -39,821,000USD | -36,696,000USD |
| Ebit | — | -20,306,000USD | -23,699,000USD | -27,509,000USD | -26,232,000USD | -9,443,000USD | -37,259,000USD | -34,500,000USD |
| Ebitda | — | -20,070,000USD | -23,476,000USD | -27,286,000USD | -25,864,000USD | -8,954,000USD | -36,986,000USD | -34,220,000USD |
| Depreciation And Amortization | — | 236,000USD | 223,000USD | 223,000USD | 368,000USD | 489,000USD | 273,000USD | 280,000USD |
| Reconciled Depreciation | — | 223,000USD | 223,000USD | 223,000USD | 355,000USD | 476,000USD | 273,000USD | 267,000USD |
| Unclassified Operating Expenses | — | — | -36,134,000USD | — | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 35,113,000USD | 2,557,000USD | 0USD | 0USD | 0USD | 3,000,000USD | 3,000,000USD | 3,500,000USD |
| Cost Of Revenue | 6,257,000USD | 797,000USD | 1,996,000USD | 1,994,000USD | 1,892,000USD | 1,230,000USD | 672,000USD | 103,000USD |
| Gross Profit | 28,856,000USD | 1,760,000USD | -1,996,000USD | -1,994,000USD | -1,892,000USD | 3,000,000USD | -672,000USD | -103,000USD |
| Research Development | 72,223,000USD | 81,643,000USD | 72,017,000USD | 61,058,000USD | 48,755,000USD | 41,932,000USD | 30,163,000USD | 20,346,000USD |
| Selling General Administrative | 43,516,000USD | 61,518,000USD | 32,141,000USD | 27,020,000USD | 24,702,000USD | 20,942,000USD | 17,640,000USD | 18,406,000USD |
| Total Operating Expenses | 115,739,000USD | 38,161,000USD | 107,522,000USD | 87,569,000USD | 73,457,000USD | 62,874,000USD | 46,131,000USD | 28,982,000USD |
| Operating Income | -86,883,000USD | -36,401,000USD | -107,522,000USD | -87,569,000USD | -75,349,000USD | -59,874,000USD | -46,803,000USD | -29,085,000USD |
| Interest Income | 4,576,000USD | 5,769,000USD | 3,335,000USD | 219,000USD | 10,000USD | 273,000USD | 1,197,000USD | 809,000USD |
| Interest Expense | 8,876,000USD | 8,768,000USD | 5,777,000USD | 3,993,000USD | 3,642,000USD | 2,688,000USD | 2,147,000USD | 720,000USD |
| Net Interest Income | -4,300,000USD | -2,999,000USD | -1,700,000USD | -3,774,000USD | -3,632,000USD | -2,415,000USD | -950,000USD | -230,000USD |
| Income Before Tax | -79,158,000USD | -37,140,000USD | -101,089,000USD | -93,839,000USD | -88,679,000USD | -61,983,000USD | -52,807,000USD | -33,284,999USD |
| Income Tax Expense | 41,000USD | 310,000USD | 78,000USD | 28,000USD | 17,000USD | 148,000USD | 3,797,000USD | 3,903,000USD |
| Tax Provision | 41,000USD | 310,000USD | 59,000USD | 28,000USD | 17,000USD | 148,000USD | — | — |
| Net Income | -79,199,000USD | -37,450,000USD | -101,167,000USD | -93,867,000USD | -88,696,000USD | -62,131,000USD | -52,807,000USD | -33,284,999USD |
| Net Income From Continuing Ops | -79,199,000USD | -37,450,000USD | -111,141,000USD | -93,867,000USD | -88,696,000USD | -62,131,000USD | -52,807,000USD | -43,021,000USD |
| Ebit | -86,883,000USD | -28,372,000USD | -95,312,000USD | -89,846,000USD | -75,349,000USD | -59,874,000USD | -46,803,000USD | -29,085,000USD |
| Ebitda | -85,606,000USD | -27,576,000USD | -94,893,000USD | -89,333,000USD | -73,457,000USD | -59,523,000USD | -46,131,000USD | -28,982,000USD |
| Depreciation And Amortization | 1,277,000USD | 796,000USD | 419,000USD | 513,000USD | 1,892,000USD | 351,000USD | 672,000USD | 103,000USD |
| Reconciled Depreciation | 1,277,000USD | 796,000USD | 481,000USD | 513,000USD | 499,000USD | 351,000USD | 103,000USD | 155,000USD |
| Total Other Income Expense Net | 7,725,000USD | -739,000USD | 6,433,000USD | -6,270,000USD | -13,330,000USD | -2,109,000USD | -6,004,000USD | -4,199,999USD |
| Unclassified Operating Expenses | — | -105,000,000USD | 3,364,000USD | — | — | — | -1,672,000USD | -9,770,000USD |
| Non Operating Income Net Other | — | — | — | -2,277,000USD | — | 579,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -96,413,000USD | -102,639,000USD | -62,131,000USD | -53,399,000USD | -36,307,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 253,063,000USD | 270,281,000USD | 290,461,000USD | 163,555,000USD | 105,168,000USD | 130,013,000USD | 146,447,000USD | 178,165,000USD |
| Cash And Equivalents | 195,095,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 218,855,000USD | 241,982,000USD | 261,577,000USD | 132,805,000USD | 72,942,000USD | 95,697,000USD | 112,175,000USD | 142,972,000USD |
| Other Current Assets | 3,337,000USD | 2,512,000USD | 3,527,000USD | 4,925,000USD | 4,956,000USD | 4,483,000USD | 5,588,000USD | 4,477,000USD |
| Other Non Current Assets | 2,991,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 97,609,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 19,366,000USD | 23,771,000USD | 25,757,000USD | 23,506,000USD | 22,896,000USD | 25,884,000USD | 32,877,000USD | 29,258,000USD |
| Other Current Liabilities | 14,125,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 523,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 155,454,000USD | 168,450,000USD | 186,290,000USD | 61,619,000USD | 3,971,000USD | 22,944,000USD | 22,149,000USD | 59,621,000USD |
| Total Equity Including Noncontrolling Interest | 155,454,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 842,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 592,000USD | — | — | — | — | — | — | — |
| Net Receivables | 2,047,000USD | 1,113,000USD | 573,000USD | 1,606,000USD | 1,865,000USD | 1,174,000USD | 1,710,000USD | 1,073,000USD |
| Property Plant Equipment Net | 765,000USD | 1,181,000USD | 1,591,000USD | 1,993,000USD | 2,900,000USD | 4,139,000USD | 4,841,000USD | 5,291,000USD |
| Goodwill | 17,351,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 3,934,000USD | 5,073,000USD | 5,696,000USD | 5,053,000USD | 7,709,000USD | 11,115,000USD | 8,621,000USD | 8,577,000USD |
| Short Term Debt | 465,000USD | 733,000USD | 994,000USD | 1,200,000USD | 1,368,000USD | 1,303,000USD | 1,251,000USD | 1,222,000USD |
| Common Stock | 96,000USD | 94,000USD | 91,000USD | 25,000USD | 8,000USD | 6,000USD | 6,000USD | 168,000USD |
| Retained Earnings | -630,952,000USD | -614,795,000USD | -594,554,000USD | -570,629,000USD | -540,814,000USD | -515,073,000USD | -515,355,000USD | -475,534,000USD |
| Accumulated Other Comprehensive Income | -123,000USD | -122,000USD | -109,000USD | -118,000USD | -138,000USD | -128,000USD | -122,000USD | -114,000USD |
| Intangible Assets | — | 9,063,000USD | 9,250,000USD | 9,438,000USD | 9,625,000USD | 9,813,000USD | 10,000,000USD | 10,188,000USD |
| Total Liab | — | 101,831,000USD | 104,171,000USD | 101,936,000USD | 101,197,000USD | 107,069,000USD | 124,298,000USD | 118,544,000USD |
| Other Current Liab | — | 17,055,000USD | 18,603,000USD | 16,661,000USD | 13,065,000USD | 12,611,000USD | 23,005,000USD | 19,459,000USD |
| Capital Stock | — | 94,000USD | 91,000USD | 25,000USD | 8,000USD | 6,000USD | 171,000USD | 168,000USD |
| Good Will | — | 17,351,000USD | 17,351,000USD | 17,351,000USD | 17,351,000USD | 17,351,000USD | 17,351,000USD | 17,351,000USD |
| Cash | — | 216,908,000USD | 217,049,000USD | 69,632,000USD | 39,220,000USD | 40,257,000USD | 55,699,000USD | 97,412,000USD |
| Cash And Short Term Investments | — | 233,720,000USD | 252,998,000USD | 122,194,000USD | 62,951,000USD | 86,951,000USD | 102,060,000USD | 134,977,000USD |
| Current Deferred Revenue | — | 910,000USD | 464,000USD | 592,000USD | 754,000USD | 855,000USD | — | — |
| Net Debt | — | -216,175,000USD | -139,764,000USD | 7,725,000USD | 38,804,000USD | 37,784,000USD | 22,387,000USD | -19,209,000USD |
| Short Long Term Debt Total | — | 733,000USD | 77,285,000USD | 77,357,000USD | 78,024,000USD | 78,041,000USD | 78,086,000USD | 78,203,000USD |
| Long Term Debt | — | 76,520,000USD | 76,291,000USD | 76,062,000USD | 75,841,000USD | 75,629,000USD | 75,425,000USD | 75,224,000USD |
| Short Term Investments | — | 16,812,000USD | 35,949,000USD | 52,562,000USD | 23,731,000USD | 46,694,000USD | 46,361,000USD | 37,565,000USD |
| Inventory | — | 4,637,000USD | 4,479,000USD | 4,080,000USD | 3,170,000USD | 3,089,000USD | 2,817,000USD | 2,445,000USD |
| Property Plant Equipment Gross | — | 2,478,000USD | 2,823,000USD | 1,993,000USD | 4,061,000USD | 6,377,000USD | 6,744,000USD | 7,109,000USD |
| Common Stock Shares Outstanding | — | 126,288,723shares | 110,556,000shares | 43,272,773shares | 7,412,990shares | 6,869,084shares | 6,764,433shares | 6,695,509shares |
| Non Current Assets Total | — | 28,299,000USD | 28,884,000USD | 30,750,000USD | 32,226,000USD | 34,316,000USD | 34,272,000USD | 35,192,999USD |
| Non Current Liabilities Total | — | 78,060,000USD | 78,414,000USD | 78,430,000USD | 78,301,000USD | 81,185,000USD | 91,421,000USD | 89,286,000USD |
| Non Current Liabilities Other | — | 526,000USD | 525,000USD | 525,000USD | 535,000USD | 567,000USD | 831,000USD | 1,218,000USD |
| Non Currrent Assets Other | — | 704,000USD | 692,000USD | 1,968,000USD | 2,350,000USD | 3,013,000USD | 2,080,000USD | 1,574,999USD |
| Net Working Capital | — | 218,211,000USD | 235,820,000USD | 109,299,000USD | 50,046,000USD | 69,813,000USD | 79,298,000USD | 113,714,000USD |
| Unclassified Non Current Liabilities | — | 1,014,000USD | 1,598,000USD | 1,843,000USD | 1,925,000USD | 4,989,000USD | 15,165,000USD | 12,844,000USD |
| Unclassified Equity | — | 783,179,000USD | 780,771,000USD | 632,316,000USD | 544,907,000USD | 538,133,000USD | 537,449,000USD | 534,933,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 290,461,000USD | 146,447,000USD | 147,258,000USD | 155,586,000USD | 117,176,000USD | 122,871,000USD | 160,698,000USD | 36,004,000USD |
| Intangible Assets | 9,250,000USD | 10,000,000USD | — | — | — | — | — | — |
| Other Current Assets | 3,527,000USD | 5,588,000USD | 7,298,000USD | 5,807,000USD | 5,344,000USD | 3,418,000USD | 1,095,999USD | 1,467,000USD |
| Total Liab | 104,171,000USD | 124,298,000USD | 96,159,000USD | 81,535,000USD | 52,764,000USD | 50,072,000USD | 31,478,000USD | 14,404,000USD |
| Total Stockholder Equity | 186,290,000USD | 22,149,000USD | 51,099,000USD | 74,051,000USD | 64,412,000USD | 72,799,000USD | 129,220,000USD | 21,600,000USD |
| Other Current Liab | 18,603,000USD | 23,005,000USD | 12,816,000USD | 12,034,000USD | 7,870,000USD | 8,018,000USD | 6,461,000USD | 4,116,000USD |
| Common Stock | 91,000USD | 6,000USD | 167,000USD | 122,000USD | 28,000USD | 16,000USD | 16,000USD | 15,000USD |
| Capital Stock | 91,000USD | 171,000USD | 167,000USD | 122,000USD | 28,000USD | 16,000USD | 16,000USD | 15,000USD |
| Retained Earnings | -594,554,000USD | -515,355,000USD | -477,905,000USD | -376,738,000USD | -282,871,000USD | -194,175,000USD | -132,044,000USD | -135,286,000USD |
| Good Will | 17,351,000USD | 17,351,000USD | 17,351,000USD | 17,351,000USD | 17,351,000USD | 27,109,000USD | 27,109,000USD | — |
| Cash | 217,049,000USD | 55,699,000USD | 99,216,000USD | 121,718,000USD | 81,787,000USD | 78,972,000USD | 126,184,000USD | 30,754,000USD |
| Cash And Short Term Investments | 252,998,000USD | 102,060,000USD | 114,216,000USD | 121,718,000USD | 81,787,000USD | 78,972,000USD | 126,184,000USD | 30,754,000USD |
| Total Current Assets | 261,577,000USD | 112,175,000USD | 122,076,000USD | 128,677,000USD | 87,878,000USD | 83,307,000USD | 129,277,999USD | 35,080,000USD |
| Total Current Liabilities | 25,757,000USD | 32,877,000USD | 22,862,000USD | 22,324,000USD | 14,023,000USD | 11,948,000USD | 9,447,000USD | 5,398,000USD |
| Current Deferred Revenue | 464,000USD | — | — | — | — | — | — | 737,000USD |
| Net Debt | -139,764,000USD | 22,387,000USD | -40,935,000USD | -83,298,000USD | -42,002,000USD | -40,524,000USD | -103,271,000USD | -22,860,000USD |
| Short Term Debt | 994,000USD | 1,251,000USD | 1,099,000USD | 2,513,000USD | 1,870,000USD | 786,000USD | 898,000USD | 1,687,000USD |
| Short Long Term Debt Total | 77,285,000USD | 78,086,000USD | 58,281,000USD | 38,420,000USD | 39,785,000USD | 38,448,000USD | 22,913,000USD | 9,581,000USD |
| Long Term Debt | 76,291,000USD | 75,425,000USD | 54,570,000USD | 32,304,000USD | 33,139,000USD | 33,178,000USD | 20,097,000USD | 7,894,000USD |
| Short Term Investments | 35,949,000USD | 46,361,000USD | 15,000,000USD | 0USD | — | — | — | — |
| Net Receivables | 573,000USD | 1,710,000USD | 562,000USD | 1,152,000USD | 747,000USD | 917,000USD | 1,998,000USD | 2,859,000USD |
| Inventory | 4,479,000USD | 2,817,000USD | 0USD | — | -747,000USD | — | — | — |
| Accounts Payable | 5,696,000USD | 8,621,000USD | 8,947,000USD | 7,777,000USD | 4,283,000USD | 3,144,000USD | 2,088,000USD | 545,000USD |
| Property Plant Equipment Net | 1,591,000USD | 4,841,000USD | 6,395,000USD | 8,333,000USD | 10,224,000USD | 9,197,000USD | 2,362,000USD | 285,000USD |
| Property Plant Equipment Gross | 2,823,000USD | 6,744,000USD | 8,014,000USD | 8,333,000USD | 10,224,000USD | 9,197,000USD | 2,362,000USD | 285,000USD |
| Accumulated Other Comprehensive Income | -109,000USD | -122,000USD | -119,000USD | -119,000USD | -119,000USD | -119,000USD | -119,000USD | 241,000USD |
| Common Stock Shares Outstanding | 42,292,818shares | 6,702,073shares | 5,927,082shares | 2,117,533shares | 858,299shares | 669,233shares | 384,333shares | 459,000shares |
| Non Current Assets Total | 28,884,000USD | 34,272,000USD | 25,182,000USD | 26,909,000USD | 29,298,000USD | 39,563,999USD | 31,420,000USD | 924,000USD |
| Non Current Liabilities Total | 78,414,000USD | 91,421,000USD | 73,297,000USD | 59,211,000USD | 38,741,000USD | 38,124,000USD | 22,031,000USD | 9,006,000USD |
| Non Current Liabilities Other | 525,000USD | 831,000USD | 432,000USD | 3,603,000USD | 826,000USD | 462,000USD | 16,000USD | 5,000USD |
| Non Currrent Assets Other | 692,000USD | 2,080,000USD | 1,436,000USD | 1,225,000USD | 402,000USD | 1,527,999USD | 47,000USD | 639,000USD |
| Net Working Capital | 235,820,000USD | 79,298,000USD | 99,214,000USD | 106,353,000USD | 73,855,000USD | 71,359,000USD | 119,831,000USD | 29,682,000USD |
| Unclassified Non Current Liabilities | 1,598,000USD | 15,165,000USD | 18,295,000USD | -23,131,000USD | 3,950,000USD | 4,022,000USD | 1,902,000USD | — |
| Unclassified Equity | 780,771,000USD | 537,449,000USD | 528,789,000USD | 450,664,000USD | 347,346,000USD | 267,061,000USD | 261,351,000USD | 156,615,000USD |
| Other Assets | — | — | 0USD | 1,225,000USD | 1,723,000USD | 11,218,000USD | 1,949,000USD | 364,000USD |
| Deferred Long Term Liab | — | — | — | 23,131,000USD | — | — | — | — |
| Other Liab | — | — | — | 23,304,000USD | 826,000USD | 462,000USD | 16,000USD | 1,356,000USD |
| Short Long Term Debt | — | — | — | 1,315,000USD | 795,000USD | — | — | 1,687,000USD |
| Net Tangible Assets | — | — | — | 56,700,000USD | 47,061,000USD | 45,690,000USD | 102,111,000USD | -77,086,000USD |
| Unclassified Non Current Assets | — | — | — | -1,225,000USD | — | -9,488,000USD | — | — |
| Unclassified Current Liabilities | — | — | — | -1,315,000USD | — | — | — | -3,374,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -20,241,000USD | -23,925,000USD | -29,815,000USD | -25,741,000USD | 282,000USD | -39,821,000USD | -36,696,000USD | 90,833,000USD |
| Depreciation | 236,000USD | 223,000USD | 223,000USD | 355,000USD | 476,000USD | 273,000USD | 280,000USD | 194,000USD |
| Stock Based Compensation | 2,413,000USD | 2,271,000USD | 760,000USD | 748,000USD | 519,000USD | 2,217,000USD | 1,820,000USD | 2,428,000USD |
| Other Non Cash Items | 2,818,000USD | 386,000USD | 1,616,000USD | -1,055,000USD | -10,365,000USD | 3,140,000USD | 4,043,000USD | -122,352,000USD |
| Change To Account Receivables | -541,000USD | 318,000USD | 254,000USD | -636,000USD | 561,000USD | — | 0USD | 0USD |
| Change To Inventory | -158,000USD | -399,000USD | -910,000USD | -81,000USD | -272,000USD | -372,000USD | -1,614,000USD | -831,000USD |
| Change In Working Capital | -2,412,000USD | 5,518,000USD | -606,000USD | -4,208,000USD | -3,280,000USD | 1,196,000USD | -1,659,000USD | 1,048,000USD |
| Total Cash From Operating Activities | -19,599,000USD | -15,527,000USD | -27,822,000USD | -29,901,000USD | -12,368,000USD | -32,995,000USD | -34,032,000USD | -30,277,000USD |
| Capital Expenditures | -19,599,000USD | -3,000,000USD | -3,000,000USD | 0USD | -3,000,000USD | -41,000USD | -92,000USD | -134,000USD |
| Free Cash Flow | -19,599,000USD | -15,527,000USD | -27,822,000USD | -29,901,000USD | -12,368,000USD | -33,036,000USD | -34,124,000USD | -30,411,000USD |
| Investments | 19,252,000USD | 16,849,000USD | -28,669,000USD | 23,112,000USD | -3,138,000USD | -8,621,000USD | -15,929,000USD | 96,862,000USD |
| Total Cashflows From Investing Activities | 19,252,000USD | 16,849,000USD | -28,669,000USD | 23,112,000USD | -3,138,000USD | -8,621,000USD | -15,929,000USD | 96,862,000USD |
| Total Cash From Financing Activities | 2,000USD | 146,092,000USD | 86,905,000USD | 5,631,000USD | 0USD | 135,000USD | 0USD | 20,159,000USD |
| Change In Cash | -944,000USD | 147,417,000USD | 30,413,000USD | -1,037,000USD | -15,434,000USD | -41,725,000USD | -49,806,000USD | 86,725,000USD |
| Begin Period Cash Flow | 217,852,000USD | 70,435,000USD | 40,022,000USD | 40,257,000USD | 56,475,000USD | 98,200,000USD | 147,218,000USD | 60,493,000USD |
| End Period Cash Flow | 216,908,000USD | 217,852,000USD | 70,435,000USD | 39,220,000USD | 41,041,000USD | 56,475,000USD | 97,412,000USD | 147,218,000USD |
| Other Cashflows From Financing Activities | 2,000USD | 98,000USD | -46,000USD | — | — | 294,000USD | -159,000USD | 159,000USD |
| Unclassified Operating Cash Flow | -2,413,000USD | — | — | — | — | — | -1,820,000USD | -2,428,000USD |
| Unclassified Investing Cash Flow | 19,599,000USD | — | 6,000,000USD | — | 6,000,000USD | — | — | -97,866,000USD |
| Net Borrowings | — | 0USD | 0USD | — | — | 0USD | 0USD | — |
| Sale Purchase Of Stock | — | -46,000USD | — | 46,000USD | — | — | — | — |
| Issuance Of Capital Stock | — | 145,994,000USD | 86,951,000USD | — | — | -159,000USD | 159,000USD | — |
| Other Cashflows From Investing Activities | — | 3,000,000USD | -3,000,000USD | — | -3,000,000USD | — | — | 98,000,000USD |
| Unclassified Financing Cash Flow | — | 146,040,000USD | — | 5,585,000USD | — | — | — | 20,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -79,199,000USD | -37,450,000USD | -101,167,000USD | -93,867,000USD | -88,696,000USD | -62,131,000USD | -52,807,000USD | -33,284,999USD |
| Depreciation | 1,277,000USD | 796,000USD | 419,000USD | 513,000USD | 1,892,000USD | 1,230,000USD | 103,000USD | 103,000USD |
| Stock Based Compensation | 4,298,000USD | 8,204,000USD | 8,687,000USD | 5,199,000USD | 6,180,000USD | 5,428,000USD | 2,050,000USD | 5,620,000USD |
| Other Non Cash Items | -9,418,000USD | -105,126,000USD | -4,795,000USD | 5,317,000USD | 17,397,000USD | 6,145,999USD | 7,988,000USD | 4,626,999USD |
| Change To Account Receivables | 497,000USD | -1,070,000USD | -1,370,000USD | -610,000USD | — | -1,655,000USD | — | -1,374,000USD |
| Change To Inventory | -1,662,000USD | -2,817,000USD | 0USD | 610,000USD | — | — | — | — |
| Change In Working Capital | -2,576,000USD | 2,675,000USD | 344,000USD | 5,736,000USD | -1,498,000USD | -4,062,999USD | -3,236,000USD | 3,135,000USD |
| Total Cash From Operating Activities | -85,618,000USD | -130,901,000USD | -96,512,000USD | -77,102,000USD | -70,905,000USD | -58,818,000USD | -48,055,000USD | -25,420,000USD |
| Capital Expenditures | -3,000,000USD | -7,326,000USD | -60,000USD | -103,000USD | -615,000USD | -1,362,000USD | -174,000USD | -34,000USD |
| Free Cash Flow | -88,618,000USD | -138,227,000USD | -96,572,000USD | -77,205,000USD | -71,520,000USD | -60,180,000USD | -48,229,000USD | -25,420,000USD |
| Investments | 11,154,000USD | 66,990,000USD | -10,084,000USD | -103,000USD | -615,000USD | -1,362,000USD | 27,232,000USD | -34,000USD |
| Total Cashflows From Investing Activities | 8,154,000USD | 66,990,000USD | -14,883,000USD | -103,000USD | -615,000USD | -1,362,000USD | 27,232,000USD | -34,000USD |
| Net Borrowings | 0USD | 20,000,000USD | 20,436,000USD | -795,000USD | 0USD | 12,388,000USD | 481,000USD | 3,528,000USD |
| Total Cash From Financing Activities | 238,628,000USD | 20,294,000USD | 88,516,000USD | 117,230,000USD | 74,245,000USD | 12,394,000USD | 140,661,000USD | 6,870,000USD |
| Issuance Of Capital Stock | 238,530,000USD | 0USD | 122,007,000USD | 122,631,000USD | 75,985,000USD | 55,000,000USD | 139,388,000USD | 0USD |
| Change In Cash | 161,377,000USD | -43,773,000USD | -22,780,000USD | 39,920,000USD | 2,815,000USD | -47,212,000USD | 119,588,000USD | -68,659,000USD |
| Begin Period Cash Flow | 56,475,000USD | 100,248,000USD | 123,028,000USD | 83,108,000USD | 78,972,000USD | 126,184,000USD | 8,498,000USD | 76,793,000USD |
| End Period Cash Flow | 217,852,000USD | 56,475,000USD | 100,248,000USD | 123,028,000USD | 81,787,000USD | 78,972,000USD | 128,086,000USD | 8,134,000USD |
| Other Cashflows From Investing Activities | -3,000,000USD | 98,000,000USD | — | 4,802,000USD | -615,000USD | -1,362,000USD | 1,000,000USD | 1,000,000USD |
| Other Cashflows From Financing Activities | 98,000USD | 294,000USD | 8,081,000USD | -4,606,000USD | 260,000USD | -278,000USD | 10,641,000USD | 4,667,000USD |
| Unclassified Investing Cash Flow | 3,000,000USD | -90,674,000USD | -4,739,000USD | -4,699,000USD | 1,230,000USD | 2,724,000USD | — | — |
| Sale Purchase Of Stock | — | — | 0USD | -12USD | -2,000,000USD | -277,000USD | 19,952,000USD | -1,126,000USD |
| Unclassified Financing Cash Flow | — | — | 59,999,000USD | 122,631,024USD | 89,928,000USD | 12,949,000USD | 129,539,000USD | — |
| Change To Liabilities | — | — | — | 7,228,000USD | 1,166,000USD | 1,031,000USD | -2,752,000USD | 1,307,000USD |
| Dividends Paid | — | — | — | -12USD | -13,943,000USD | -12,388,000USD | -19,952,000USD | — |
| Cash And Cash Equivalents Changes | — | — | — | 40,025,000USD | — | -47,786,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | -6,180,000USD | -5,428,000USD | -2,153,000USD | -5,620,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | License And Other Revenue | 6,433,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 2,373,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | License And Other Revenue | 239,000 | USD | 0001501697-26-000040 |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 2,469,000 | USD | 0001501697-26-000040 |
| FY 2025Yearly · 2025-12-31 | Product | License And Other Revenue | 28,590,000 | USD | 0001501697-26-000018 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 6,523,000 | USD | 0001501697-26-000018 |
| Q1 2025Quarterly · 2025-03-31 | Product | License And Other Revenue | 27,865,000 | USD | 0001501697-26-000040 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 942,000 | USD | 0001501697-26-000040 |
| FY 2024Yearly · 2024-12-31 | Product | License And Other Revenue | 0 | USD | 0001501697-26-000018 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 2,557,000 | USD | 0001501697-26-000018 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.